Bizarre Patents
A Receptacle for supporting, rotating and sculpting a portion of ice cream or similarly malleable food while it is being consumed.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7765883 | Dry blending aid A method of monitoring and evaluating the dry-blending of powders and granular materials via the use of non-dissolvable particulate matter such as mustard seed as a blending aid. The mustard seed is blended into the total batch of dry blend materials and the mustard... | 08/03/2010 |
| 7736847 | Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics Embodiments of the present invention generally relate to novel methods for the treatment and/or prevention of neurological symptoms caused by an avian reovirus, enteric reovirus strain (ERS), and associated characteristics. Other embodiments generally comprise an im... | 06/15/2010 |
| 7670994 | Method for treating oil and gas wells A two step process for treating an oil or gas well. The first step uses a cross linking agent, such as borax, as a preliminary wash for the well following drilling. The cross linking agent cleans the well of excess mud and pre-coats the tubing and the formation surf... | 03/02/2010 |
| 7482020 | Process for making an adjuvanted vaccine comprising host albumin A process for making an adjuvanted vaccine comprising host albumin. The process comprises mixing host serum or host serum with an antigen, and then mixing the resulting mixture with an adjuvant. ... | 01/27/2009 |
| 7435422 | Non-animal origin stabilizers and processes for producing the same Embodiments of the present invention generally comprise stabilizers for biological products that are free from animal origin excipients/components, such stabilizers functioning well in lyophilization procedures. ... | 10/14/2008 |
| D569476 | Fuel dispenser container | 05/20/2008 |
| 7244434 | Replicons of pestviruses that do not express C and or E1 protein and infectious viral particles containing same, that can be used in vaccines The present invention provides new Pestiviral RNA genomes (replicons) that are able to replicate, and can be packaged into infectious viral particles in cells that complement the missing protein(s), but do not produce infectious progeny virus. Such replicons can be ... | 07/17/2007 |
| 7183367 | Vinyl sulphone modified polymer There is provided a polymer having a side chain of general formula (I) in which R may be any suitable alkyl, oxyalkyl, aryl or oxyaryl linking group R is preferably C1-6 alkyl (especially —CH2—), a benzene group or a group —CH2... | 02/27/2007 |
| 7090854 | Chicken anaemia viruses of low pathogenicity The present invention provides a new antigenic type of chicken anaemia viruses (CAV). The CAV according to this invention is isolatable from turkeys in the field and its virulence for chickens is significantly reduced. This property makes these viruses particularly ... | 08/15/2006 |
| 7090849 | vaccine The present invention relates to nucleic acid sequences encoding novel Babesia canis associated proteins and to cDNA fragments, recombinant DNA molecules and live recombinant carriers comprising these sequences. Furthermore, the invention relates to host cell... | 08/15/2006 |
| 7060282 | Attenuated equine herpesvirus The present invention relates to novel Equine herpesvirus (EHV) mutants comprising one or more deletions, substitutions, or insertions in the endogenous promoter region of an essential viral gene, preferably the immediate early gene of EHV. The EHV mutants are stabl... | 06/13/2006 |
| 7026113 | EIA vaccine and diagnostic The invention provides an equine infectious anemia (EIA) vaccine that provides immunity to mammals, especially equines, from infection with equine infectious anemia virus (EIAV) and which allows differentiation between vaccinated and non-vaccinated, but exposed, mam... | 04/11/2006 |
| 7022327 | Recombinant birnavirus vaccine The present invention provides a birnavirus mutant which is suited as vaccine candidate in eradication control programmes. The mutant is not able to produce a native VP5 protein, and this feature can be used as a marker to distinguish between animals vaccinated with... | 04/04/2006 |
| 6987124 | Use of serotonergic compound for a method of treatment of hot flushes in post-menopausal women The present invention relates to a method of treatment of hot flushes with a 5-HT2C receptor agonist and in particular to the use of the selective 5-HT2C receptor agonists 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl]-piperazine and (S)-(+)-3-[(... | 01/17/2006 |
| 6966992 | Method of purification of molecules using unbranched terminal alkyldiols The current invention provides methods for molecule purification by RP-LC and RP-HPLC that uses unbranched terminal alkyldiols as eluting solvents. In particular, the present invention purifies molecules, particularly proteins and peptides, on reverse phase liquid c... | 11/22/2005 |
| 6955892 | Feeding processes for fermentation Embodiments of the present invention generally relate to novel fed-batch fermentations wherein processes of DO-stat and pH-stat are combined for nutrient feeding control. ... | 10/18/2005 |
| 6951650 | Antigenic class of avian reoviruses The present invention provides a new antigenic class of avian reoviruses which are involved in enteric disease conditions in poultry. Moreover, the invention provides a vaccine for use in the protection of poultry against such disease conditions derived from the new... | 10/04/2005 |
| 6939558 | Intravaginal devices containing progesterone for estrus synchronization and related proceses Embodiments of the present invention generally relate to devices and processes related to estrus synchronization. Particular embodiments of devices and processes of the present invention slowly release progesterone over a period of time for estrus synchronization. | 09/06/2005 |
| 6887479 | Attenuated recombinant rabies virus mutants and live vaccines thereof The present invention describes recombinant RV mutants comprising a combine mutation in two different parts of the viral genome, involving the P and the G genes. The mutations in the P gene preferably encompass residues 139 to 170, more preferably residue 139 to 149... | 05/03/2005 |
| 6864357 | Process for the preparation of peptides The present invention relates to a process for the preparation of peptides using an excess of an activated carboxylic component to acylate an amino component, wherein after the acylation an amine comprising a free anion or a latent anion is used as a scavenger of re... | 03/08/2005 |
| 6821752 | Methods and compositions for extracting proteins from cells The present invention relates to a process of releasing a protein, recombinant or otherwise, from a cell. The process of the present invention involves contacting a host cell containing a protein of interest with a solution comprising one or more detergents and one ... | 11/23/2004 |
| 6805877 | Intravaginal devices containing progesterone for estrus synchronization and related processes Embodiments of the present invention generally relate to devices and processes related to estrus synchronization. Particular embodiments of devices and processes of the present invention slowly release progesterone over a period of time for estrus synchronization. | 10/19/2004 |
| 6790446 | Campylobacter vaccine The present invention relates to vaccines comprising antiserum raised against a flagellaless Campylobacter strain for the prevention of Campylobacter colonization in animals. The invention also relates to antigenic Campylobacter proteins visible in a Western blot of... | 09/14/2004 |
| 6780854 | Orally active androgens Novel, orally active androgens are 7α-substituted Δ14-nandrolone derivatives. The compounds satisfy the general formula: wherein R1 is O, (H,H), (H,OR), NOR, with R being hydrogen, (C1... | 08/24/2004 |
| 6770275 | Live attenuated RTX-producing bacteria of the family pasteurellaceae The present invention relates to live attenuated RTX-toxin producing bacteria of the family Pasteurellaceae, of which the attenuation is due to the fact that they produce RTX toxin in a non-activated form. The invention also relates to vaccines for the protection of... | 08/03/2004 |
| 6743430 | Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose Disclosed herein is a multicomponent low dose vaccine comprising a safe and immunogenically effective combination of a protective antigen component or components of clostridial organism, a protective antigen component of a non-clostridial organism and an adjuvant. | 06/01/2004 |
| 6727078 | EIAV p26 deletion vaccine and diagnostic Disclosed herein is a vaccine which provides immunity to mammals from infection and/or disease caused by a lentivirus, such as equine infectious anemia virus, human immunodeficiency virus (HIV), feline immunodeficiency virus (FIV), bovine immunodeficiency virus (BIV... | 04/27/2004 |
| 6723324 | Chicken anaemia viruses of low pathogenicity The present invention provides a new antigenic type of chicken anaemia viruses (CAV). The CAV according to this invention is isolatable from turkeys in the field and its virulence for chickens is significantly reduced. This property makes these viruses particularly ... | 04/20/2004 |
| 6682746 | Adjuvanted vaccine which is substantially free of non-host albumin Disclosed herein is a serum-based adjuvanted vaccine which is substantially free of non-host albumin and the use thereof in reducing or preventing post-vaccination systemic reactions.... | 01/27/2004 |
| 6635679 | Methods and compositions for inactivating viruses The present invention relates to methods and processes of inactivating a viral contaminants in a biological source material or process intermediate by contacting the biological source material (e.g., a host cell, cell supernatant, cell lysate, blood plasm... | 10/21/2003 |
| 6585978 | EIA vaccine and diagnostic The invention provides an equine infectious anemia (EIA) vaccine that provides immunity to mammals, especially equines, from infection with equine infectious anemia virus (EIAV) and which allows differentiation between vaccinated and non-vaccinated, but e... | 07/01/2003 |
| 6569422 | Genetically engineered cell culture adapted infectious bursal diseases virus (IBDV) mutants The present invention relates to a method for the adaptation of infectious bursal disease viruses (IBDV) to growth in CEF cell culture. Changing the codons for amino acid residues 253 (Gln) and 284 (Ala) to 253 (His) and 284 (Thr) allowed bursa adapted Cl... | 05/27/2003 |
| 6492148 | Genetically engineered cell culture adapted infectious bursal disease virus (IBDV) mutants The present invention relates to a method for the adaptation of infectious bursal disease viruses (IBDV) to growth in CEF cell culture. Changing the codons for amino acid residues 253 (Gln) and 284 (Ala) to 253 (His) and 284 (Thr) allowed bursa adapted Cl... | 12/10/2002 |
| 6485940 | Broad spectrum infectious bursal disease virus vaccine The present invention provides a broad spectrum IBDV vaccine that is able to induce a protective immune response against classical- and variant E IBDV strains. Moreover, the vaccine can be administered to poultry by mass application routes.... | 11/26/2002 |
| 6486354 | Solid phase supports Embodiments of the present invention generally relate to carrying out organic chemistry on solid supports comprising derivatised functionalities, methods for synthesizing said supports, methods for synthesizing compounds comprising amine groups or N-conta... | 11/26/2002 |
| 6437101 | Methods for protein purification using aqueous two-phase extraction Methods are provided in this invention for the isolation of human growth hormone, growth hormone antagonist, or a homologue of either, from a biological source. The methods of the invention use multi-phase extraction.... | 08/20/2002 |
| 6425879 | Needle-less injector The present invention relates to a needle-less injector having a housing comprising: a chamber defined within said injector for containing liquid to be injected; a liquid outlet for said chamber positioned at the front end of the injector; a dispensing me... | 07/30/2002 |
| 6413532 | Repellent pest control system A repellent solid pest control system which includes a polymeric matrix, a liquid plasticizer, a pest control active ingredient and triphenyl phosphate as a carrier for the active ingredient. Protection of dogs from bites of phlebotomine sandflies by usin... | 07/02/2002 |
